Myocardial Ischemia and Reperfusion Injury

Myocardial ischemia is the state in which heart muscle receives too little blood to meet its metabolic needs, and reperfusion injury is the paradoxical additional damage that can occur when blood flow is restored to previously ischemic myocardium. Together they explain both the harm of interrupted coronary flow and the limits of simply restoring it.

Definition

Myocardial ischemia is an imbalance in which myocardial oxygen and substrate supply fall below demand, while ischemia-reperfusion injury is the additional cardiomyocyte damage triggered by the abrupt restoration of blood flow and oxygen to ischemic tissue.

Scope

This topic covers the cellular consequences of myocardial ischemia and the distinct injury that accompanies reperfusion, including mechanisms such as calcium overload, oxidative stress, and the mitochondrial permeability transition, and the concept of cardioprotection. It is mechanistically focused and especially relevant where myocardium is deliberately arrested and reperfused, but it is a reference description rather than clinical guidance.

Core questions

• What happens to cardiomyocyte metabolism and ion balance during ischemia?
• Why can restoring blood flow cause further injury rather than only rescue?
• What roles do reactive oxygen species, calcium overload, and the mitochondrial permeability transition pore play?
• Can ischemia-reperfusion injury be limited by cardioprotective strategies?

Key concepts

• Supply-demand oxygen imbalance
• Reactive oxygen species
• Intracellular calcium overload
• Mitochondrial permeability transition pore
• Reperfusion injury
• Ischemic preconditioning and postconditioning
• Cardioprotection

Key theories

Mitochondrial permeability transition pore as a death switch

Reperfusion conditions — calcium overload, oxidative stress, and pH normalization — open the mitochondrial permeability transition pore in the first minutes of reflow, collapsing mitochondrial function and committing previously viable cardiomyocytes to death, making the pore a proposed target for cardioprotection.

Conditioning-based cardioprotection

Brief, controlled episodes of ischemia before (preconditioning), after (postconditioning), or remote from the heart can activate endogenous signaling that reduces reperfusion injury in experimental models, though translation to consistent clinical benefit has been difficult.

Mechanisms

During ischemia, oxygen deprivation shifts cardiomyocytes to anaerobic metabolism, depleting high-energy phosphates, lowering intracellular pH, and disturbing ion homeostasis so that sodium and then calcium accumulate (Yellon, 2007). When flow is restored, the sudden reintroduction of oxygen generates reactive oxygen species, intracellular and mitochondrial calcium overload worsens, and rapid pH normalization permits opening of the mitochondrial permeability transition pore, which can tip reversibly injured cells into death — the core of reperfusion injury (Hausenloy, 2013). Because some injury is caused by reperfusion itself, experimental cardioprotective strategies such as ischemic conditioning aim to interrupt these pathways, though their clinical translation has been inconsistent (Heusch, 2016).

Clinical relevance

The dual nature of ischemia and reperfusion explains why restoring coronary flow is necessary but not by itself sufficient to fully protect myocardium, a concept central to reperfusion of infarcted hearts and to settings where the heart is deliberately arrested and restarted (Anderson, 2017; Yellon, 2007). This entry describes mechanisms for reference and does not direct the care of any individual.

Evidence & guidelines

Reperfusion injury and cardioprotection are characterized largely through experimental and translational research; while preconditioning and conditioning reduce injury in models, critical appraisals of clinical trials have found inconsistent benefit, so no conditioning therapy has become standard of care (Heusch, 2016; Hausenloy, 2013).

History

The recognition that reperfusion can itself injure myocardium emerged from experimental cardiology in the late twentieth century, alongside the discovery of ischemic preconditioning. Reviews by Yellon and Hausenloy (2007) and Hausenloy and Yellon (2013) consolidated the mechanistic picture and proposed the mitochondrial permeability transition pore as a therapeutic target, while Heusch (2016) critically appraised the clinical translation of conditioning.

Debates

Can cardioprotection against reperfusion injury be translated to patients?

Ischemic and pharmacological conditioning robustly limit infarct size in animal models, but clinical trials of pre-, post-, and remote conditioning have given mixed results, raising the question of whether the experimental concept can yield reliable patient benefit.

Key figures

• Derek M. Yellon
• Derek J. Hausenloy
• Gerd Heusch

Seminal works

• yellon-2007
• hausenloy-2013

Frequently asked questions

How can restoring blood flow harm the heart it is meant to save?

Reperfusion is essential to rescue ischemic muscle, but the sudden return of oxygen and the conditions at reflow can generate reactive oxygen species and calcium overload that open the mitochondrial permeability transition pore, killing some cells that were still viable. This added damage is called reperfusion injury.

Does ischemic preconditioning protect the heart in patients?

In experimental models, brief episodes of ischemia before a longer one markedly reduce injury. In patients, however, trials of conditioning strategies have shown inconsistent results, so it remains a research concept rather than an established treatment.